Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels.

DPP-4 inhibitors have been shown to reverse amyloid deposition in Alzheimer's disease (AD) patients with cognitive impairment. Ocimum sanctum L. leaves reported the presence of important phytoconstituents which are reported to have DPP-4 inhibitory activity. To investigate the effects of petroleum ether extract of Ocimum sanctum L. (PEOS) in Intracerebroventricular streptozotocin (ICV-STZ) induced AD rats. ICV-STZ (3 mg/kg) was injected bilaterally into male Wistar rats, while sham animals received the artificial CSF. The ICV-STZ-induced rats were administered with three doses of PEOS (100, 200, and 400 mg/kg, p.o.) for thirty days. All experimental rats were subjected to behaviour parameters (radial arm maze task and novel object recognition test), neurochemical parameters such as GLP-1, Aß42, and TNF-α levels, and histopathological examination (Congo red staining) of the left brain hemisphere. PEOS significantly reversed the spatial learning and memory deficit exhibited by ICV-STZ-induced rats. Furthermore, PEOS also shows promising results in retreating Aß deposition, TNF α, and increasing GLP-1 levels. The histopathological study also showed a significant dose-dependent reduction in amyloid plaque formation and dense granule in PEOS -treated rats as compared to the ICV-STZ induced rats (Negative control). The results show that extract of Ocimum sanctum L. attenuated ICV-STZ-induced learning and memory deficits in rats and has the potential to be employed in the therapy of AD.

Evaluation of results of various tendon transfers in high and low radial nerve palsy.

BACKGROUND: Various combinations of tendon transfers are available for radial nerve palsy. However, the choice of which set of transfer to be performed in a patient remains an issue of varied opinions among surgeons. The study attempts to evaluate the results of various tendon transfers for radial nerve palsy quantitatively and subjectively. It also identifies which set of transfer is suitable for particular groups of patients. MATERIALS AND METHODS: The study was conducted between 2005 and 2007. A total of 15 tendon transfers were performed using various combinations and evaluated according to Bincaz's criteria, Kapandji scale and effect of tendon transfers on activities of daily living. RESULTS: 13 patients had excellent to fair outcome according to Bincaz's criteria. 2 patients had poor outcome. There was no hindrance in the activities of daily life in all patients. 93.4% of patients were satisfied with the results. CONCLUSION: Every combination of tendon transfers has its own set of merits and demerits. Selection of donor tendons as per occupational need of patients is utmost important. Patients in our series were satisfied with set of transfers using Pronator teres(PT) for wrist extension, Flexor carpi radialis (FCR) for finger extension and rerouted Palmaris longus (PL) for extension of thumb. Flexor carpi ulnaris (FCU) is important for power grip.

Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin.

OBJECTIVES: The aim of this study was to develop and optimize levofloxacin loaded PLGA nanoparticles (LN) for pulmonary delivery employing screening and experimental design and evaluate their in-vitro and in-vivo performance. The objective was to achieve Mass Median Aerodynamic Diameter (MMAD) of LN of less than 5µm, sustain the drug release up to 120 h and a higher AUC/MIC at the site of action. METHODS: LN were prepared by modified emulsion solvent evaporation technique employing high speed homogenization, probe sonication and subsequent lyophilization. KEY FINDINGS: The Pareto chart from Placket Burman screening design revealed that homogenization speed and amount of PLGA were found to be significant (P < 0.05). Further analysis by 3 full-factorial design revealed that F-ratio was found to be far greater than the theoretical value (P < 0.05) for each regression model. CONCLUSION: The optimized formulation with desirability value 0.9612 showed mean particle size of 146 nm, MMAD of 4.40 µm and sustained the drug release up to 120 h in simulated lung fluid. Augmentation in Cmax (1.71-fold), AUC 0-∞ (5.46-fold), Mean Residence Time (6.64-fold) and AUC/MIC (6.21-fold) of LN through pulmonary route was found to significantly higher (P < 0.05) than levofloxacin (p. o.).

Retrospective Analysis of Giant Cell Tumor Lower End Radius Treated with En bloc Excision and Translocation of Ulna.

BACKGROUND: Distal end of radius is third most common site for GCT of long bones and 1% of these metastasize mostly to lungs. Reconstruction methods commonly used are fibula (vascularized and nonvascularized), centralization of ulna, translocation of ulna, and endoprosthetic replacement. We report the outcome of series of twenty cases where we did en bloc excision of tumor with translocation of ulna. MATERIALS AND METHODS: Twenty cases of giant cell tumor (GCT) of lower end of radius were included in this retrospective study. The mean age of patients was 33.15 years (range 21-55 years). We had 14 of Campanacci Grade III and 6 of Grade II. Preoperative radiographs and magnetic resonance imaging of the involved wrist and forearm were done. RESULTS: Of all twenty patients, 14 were males and 6 were females. Mean followup duration was 3.9 years (range 1.5-17 years). Mean grip strength of involved side as a percentage of normal side was 71% (range 42%-86%) and the actual mean value for operated side was 29 kg as compared to 40 kg for normal side. The average range of forearm movement was supination 80.25° (60°-90°) and pronation 77.5° (70°-90°). No patient was dissatisfied as far as cosmesis was concerned. DISCUSSION: In our opinion considering the propensity to recur with more aggressiveness after recurrence, en bloc excision with translocation of ulna has become a standard treatment option for GCT of lower end of radius, with advantages of better functional outcomes, retained vascularity, and elimination of risk of donor site morbidity.

Profound hypoglycemia presents with reversible symmetrical ADC signal changes isolated to eloquent cortex of the parietal lobe.

MRI diffusion/ADC signal change with reversal, symmetrically isolated to the cortex of the precentral gyri in profound hypoglycemia has not been previously described. We present a case in which minimal cortical signal change without deep gray matter involvement and subsequent reversal occurred without significant clinical improvement. Correlation of the reversal of diffusion/ADC signal to findings by EEG evaluation has been described in animal studies and not in humans before.

Contrast volume reduction with superior vena cava catheter-directed coronary CT angiography: comparison with peripheral i.v. contrast enhancement in a swine model.

OBJECTIVE: Conventional MDCT angiography uses a traditional peripheral i.v. approach for contrast injection; however, we describe our experience with a superior vena cava (SVC) catheter approach for coronary artery MDCT angiography as a potential means of decreasing iodinated contrast volume. CONCLUSION: Central SVC contrast injection can decrease the contrast volume by 50% while maintaining coronary attenuation similar to that of peripheral i.v. injection. This approach has potential in reducing the contrast volume on coronary MDCT angiography studies and therefore the risk of contrast-induced nephropathy in certain high-risk patients. Further studies with higher injection rates and faster scan acquisition are needed for defining a lower contrast volume threshold.

Aortic root catheter-directed coronary CT angiography in swine: coronary enhancement with minimum volume of iodinated contrast material.

OBJECTIVE: The purpose of this study was to evaluate the minimum amount of contrast material for coronary imaging with aortic root catheter-directed enhancement and 64-MDCT angiography (MDCTA). MATERIALS AND METHODS: A 64-MDCT scanner was used after animal institutional review board approval to study four swine (40-60 kg). Heart rate reduction to 65 beats per minute was achieved with atenolol by mouth and i.v. Cardizem. Common femoral artery access was obtained with a 5-French micropuncture kit and sonographic guidance. A diffusiontip (640 side holes), 5-French pigtail catheter was positioned in the aortic root on the CT table with a retrofitted C-arm fluoroscopy unit and connected to an arterial power injector. Aortic root MDCTA (retrospective ECG gating; collimation, 0.6 mm; tube rotation time, 0.33 second; scanning time, 10-12 seconds; tube voltage, 120 kVp; effective mAs, 850 mAs; pitch, 0.2; field of view, 109-123 mm; slice thickness and increment, 0.6 and 0.3 mm) was begun 1 second after the injection of 100 mL of various Visipaque (iodixanol) concentrations (10%, 20%, 30%, 40%) at 10 mL/s. Coronary mean and peak densities, 3D maximum intensity projections, and 4D projections were obtained. RESULTS: The mean pooled coronary attenuation values (H +/- SD) for the right (RCA), left anterior descending (LAD), and left circumflex (LCx) coronary arteries at various concentrations (10%, 20%, 30%, 40%) were as follows: 10% (RCA [232.6 +/- 64.0], LAD [180.4 +/- 45.1], and LCx [176.6 +/- 56.2]); 20% (RCA [383.0 +/- 98.7], LAD [324.3 +/- 60.1], and LCx [331.8 +/- 105.5]); 30% (RCA [441.8 +/- 137.6], LAD [401.3 +/- 125.8], and LCx [418.5 +/- 173.0]); and 40% (RCA [717.3 +/- 377.7], LAD [573.3 +/- 233.3], and LCx [584.8 +/- 189.0]). Coronary imaging with aortic root MDCTA was feasible at all concentrations, and the attenuation values were statistically significantly greater than 250 H at 20%, 30%, and 40% (p < 0.05). The attenuation values with aortic root MDCTA using one fifth of the volume of contrast material are comparable to those currently achieved both clinically and experimentally with peripheral i.v. MDCTA. CONCLUSION: Aortic root MDCTA can depict the coronary arteries with as little as 20 mL of contrast material. This may provide an alternative means of coronary evaluation in patients with renal insufficiency.